07 Jan 2001

Becozyme c - España

Updated: 07 Jan 2001

Becozyme c forte 30 grageas

Profilaxis de estados carenciales de vitaminas del grupo B y vitamina C: Restricciones dietéticas, malabsorción, tratamiento.

Becozyme c Description, Presentation and Dosage

Becozyme c Description

Becozyme c Drug Class Description

Complejo b, otras asociaciones

Becozyme c Drug Description

GRAGEAS

Becozyme c Presentation

Becozyme c Presentation

Dosis usual: 1-3 grageas al día.

Becozyme c Manufacturer

ROCHE

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Becozyme c Dosage

Becozyme c Precautions, Reactions and Contraindications

Becozyme c Special Precautions

Related Drugs - Gastroenterologia

Back to top